Literature DB >> 2368863

The mortality profile of black Seventh-Day Adventists residing in metropolitan Atlanta: a pilot study.

F G Murphy1, D S Blumenthal, J Dickson-Smith, R P Peay.   

Abstract

Mortality information was gathered for 110 Black Seventh-day Adventist members of seven churches in Metropolitan Atlanta, Georgia during the period 1980-87. Seventy-seven percent of the deaths were due to cardiovascular diseases; 8 percent due to cancer, the second leading cause of death. The cancer rate is extremely low in comparison to the proportion of deaths due to cardiovascular diseases. Subsequent research on this population will take into consideration lifestyle factors which could contribute to this finding.

Entities:  

Mesh:

Year:  1990        PMID: 2368863      PMCID: PMC1404764          DOI: 10.2105/ajph.80.8.984

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  The Tromsø Heart Study: coronary risk factors in Seventh-Day Adventists.

Authors:  V Fønnebø
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

2.  Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists.

Authors:  H A Kahn; R L Phillips; D A Snowdon; W Choi
Journal:  Am J Epidemiol       Date:  1984-05       Impact factor: 4.897

3.  Vegetarian diet, lifestyle and blood pressure in two religious populations.

Authors:  I L Rouse; B K Armstrong; L J Beilin
Journal:  Clin Exp Pharmacol Physiol       Date:  1982 May-Jun       Impact factor: 2.557

4.  Coffee consumption and risk of fatal cancers.

Authors:  D A Snowdon; R L Phillips
Journal:  Am J Public Health       Date:  1984-08       Impact factor: 9.308

5.  Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: preliminary results.

Authors:  R L Phillips; D A Snowdon
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.